Novel Anticancer Strategies (Volume II)
Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original a...
Na minha lista:
| Formato: | Online |
|---|---|
| Idioma: | inglês |
| Publicado em: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Assuntos: | |
| Acesso em linha: | ONIX_20230405_9783036570334_212 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
| _version_ | 1869523168230637568 |
|---|---|
| collection | Directory of Open Access Books |
| description | Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original and review articles devoted to key areas of major progress and expectations. Key Features:Nanoparticle-based drug delivery in cancer therapy;Nanoerythrosomes;Cancer immunotherapy;Therapeutic vaccines;Oncogenic and tumor suppressive components of the cell cycle;Antimitotics in cancer clinical trials;Multifunctional enzymes as anti-cancer drug targets;Targeting undruggable proteins and non-coding RNAs;Cell-penetrating peptides;Repurposed cancer drugs in clinical trials;Circulating tumour cells. |
| format | Online |
| id | doab-20.500.12854ir-98933 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-989332024-03-31T13:10:41Z Novel Anticancer Strategies (Volume II) Bousbaa, Hassan Breast cancer treatment Photodynamic therapy Inorganic nanoparticles Active targeting cathepsins BAX MOMP ubiquitination apoptosis chemotherapy cancer nanoerythrosome nanoerythrocyte nanovesicles biomimetic cancer therapy diagnostics imaging agents cell cycle cyclin-dependent kinase p16 p21 p27 breast cancer prognosis drug delivery HL60 leukemia prodrug resistance retinoic acid vitamin K drug repurposing COVID-19 pandemic vaccination multi-drug resistance enhanced permeation and retention effect nanotherapeutics cancer theranostic clinical translation cell-penetrating peptides protein transduction domains tumor imaging targeted therapies dog comparative oncology molecular targets spheroids tumoroids hydrogel collagen agarose mammary spheroids tissue engineering cisplatin melanoma melanin nanoparticles cytotoxicity laser medical applications hyperthermia antimitotics mitotic slippage spindle assembly checkpoint clinical trials TRAIL cancer stem cells TRAIL resistance angiogenesis on-demand drug delivery systems electrospun nanofibers poly (N-isopropylacrylamide) gold nanorods paclitaxel β-Cyclodextrin SPIONs metallodrugs RAPTA derivatives phosphino-amine ligands CTCs NSCLCs metastasis suppression curcumin flavonoids TNBC immunotherapy immune checkpoint nanocarrier combinational immunotherapy lung cancer miRNA oncomiRs photodynamic therapy PDT porphyrin iron oxide nanoparticles mesoporous silica nanoparticles antibody functionalization targeted drug delivery systems molecular-targeted therapies multifunctional enzymes HCC CHRNA5 metastasis stemness property sorafenib sensitivity neoantigens vaccine Patched chemotherapy resistance metastases persistent cells adrenocortical carcinoma BUB3 mitosis senescence anticancer target boron neutron capture therapy 4-borono-l-phenylalanine drug discovery solubility mebendazole polymer HPMA controlled drug release PLK1 BI2536 Navitoclax slippage PD-1 gemcitabine new anti-cancer drugs precision medicine undruggable targets non-coding RNAs oligonucleotide therapeutics n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original and review articles devoted to key areas of major progress and expectations. Key Features:Nanoparticle-based drug delivery in cancer therapy;Nanoerythrosomes;Cancer immunotherapy;Therapeutic vaccines;Oncogenic and tumor suppressive components of the cell cycle;Antimitotics in cancer clinical trials;Multifunctional enzymes as anti-cancer drug targets;Targeting undruggable proteins and non-coding RNAs;Cell-penetrating peptides;Repurposed cancer drugs in clinical trials;Circulating tumour cells. 2023-04-05T12:59:45Z 2023-04-05T12:59:45Z 2023 book ONIX_20230405_9783036570334_212 9783036570334 9783036570327 https://directory.doabooks.org/handle/20.500.12854/98933 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/6986 https://mdpi.com/books/pdfview/book/6986 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7032-7 10.3390/books978-3-0365-7032-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036570334 9783036570327 700 Basel open access |
| spellingShingle | Breast cancer treatment Photodynamic therapy Inorganic nanoparticles Active targeting cathepsins BAX MOMP ubiquitination apoptosis chemotherapy cancer nanoerythrosome nanoerythrocyte nanovesicles biomimetic cancer therapy diagnostics imaging agents cell cycle cyclin-dependent kinase p16 p21 p27 breast cancer prognosis drug delivery HL60 leukemia prodrug resistance retinoic acid vitamin K drug repurposing COVID-19 pandemic vaccination multi-drug resistance enhanced permeation and retention effect nanotherapeutics cancer theranostic clinical translation cell-penetrating peptides protein transduction domains tumor imaging targeted therapies dog comparative oncology molecular targets spheroids tumoroids hydrogel collagen agarose mammary spheroids tissue engineering cisplatin melanoma melanin nanoparticles cytotoxicity laser medical applications hyperthermia antimitotics mitotic slippage spindle assembly checkpoint clinical trials TRAIL cancer stem cells TRAIL resistance angiogenesis on-demand drug delivery systems electrospun nanofibers poly (N-isopropylacrylamide) gold nanorods paclitaxel β-Cyclodextrin SPIONs metallodrugs RAPTA derivatives phosphino-amine ligands CTCs NSCLCs metastasis suppression curcumin flavonoids TNBC immunotherapy immune checkpoint nanocarrier combinational immunotherapy lung cancer miRNA oncomiRs photodynamic therapy PDT porphyrin iron oxide nanoparticles mesoporous silica nanoparticles antibody functionalization targeted drug delivery systems molecular-targeted therapies multifunctional enzymes HCC CHRNA5 metastasis stemness property sorafenib sensitivity neoantigens vaccine Patched chemotherapy resistance metastases persistent cells adrenocortical carcinoma BUB3 mitosis senescence anticancer target boron neutron capture therapy 4-borono-l-phenylalanine drug discovery solubility mebendazole polymer HPMA controlled drug release PLK1 BI2536 Navitoclax slippage PD-1 gemcitabine new anti-cancer drugs precision medicine undruggable targets non-coding RNAs oligonucleotide therapeutics n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Novel Anticancer Strategies (Volume II) |
| title | Novel Anticancer Strategies (Volume II) |
| title_full | Novel Anticancer Strategies (Volume II) |
| title_fullStr | Novel Anticancer Strategies (Volume II) |
| title_full_unstemmed | Novel Anticancer Strategies (Volume II) |
| title_short | Novel Anticancer Strategies (Volume II) |
| title_sort | novel anticancer strategies volume ii |
| topic | Breast cancer treatment Photodynamic therapy Inorganic nanoparticles Active targeting cathepsins BAX MOMP ubiquitination apoptosis chemotherapy cancer nanoerythrosome nanoerythrocyte nanovesicles biomimetic cancer therapy diagnostics imaging agents cell cycle cyclin-dependent kinase p16 p21 p27 breast cancer prognosis drug delivery HL60 leukemia prodrug resistance retinoic acid vitamin K drug repurposing COVID-19 pandemic vaccination multi-drug resistance enhanced permeation and retention effect nanotherapeutics cancer theranostic clinical translation cell-penetrating peptides protein transduction domains tumor imaging targeted therapies dog comparative oncology molecular targets spheroids tumoroids hydrogel collagen agarose mammary spheroids tissue engineering cisplatin melanoma melanin nanoparticles cytotoxicity laser medical applications hyperthermia antimitotics mitotic slippage spindle assembly checkpoint clinical trials TRAIL cancer stem cells TRAIL resistance angiogenesis on-demand drug delivery systems electrospun nanofibers poly (N-isopropylacrylamide) gold nanorods paclitaxel β-Cyclodextrin SPIONs metallodrugs RAPTA derivatives phosphino-amine ligands CTCs NSCLCs metastasis suppression curcumin flavonoids TNBC immunotherapy immune checkpoint nanocarrier combinational immunotherapy lung cancer miRNA oncomiRs photodynamic therapy PDT porphyrin iron oxide nanoparticles mesoporous silica nanoparticles antibody functionalization targeted drug delivery systems molecular-targeted therapies multifunctional enzymes HCC CHRNA5 metastasis stemness property sorafenib sensitivity neoantigens vaccine Patched chemotherapy resistance metastases persistent cells adrenocortical carcinoma BUB3 mitosis senescence anticancer target boron neutron capture therapy 4-borono-l-phenylalanine drug discovery solubility mebendazole polymer HPMA controlled drug release PLK1 BI2536 Navitoclax slippage PD-1 gemcitabine new anti-cancer drugs precision medicine undruggable targets non-coding RNAs oligonucleotide therapeutics n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | Breast cancer treatment Photodynamic therapy Inorganic nanoparticles Active targeting cathepsins BAX MOMP ubiquitination apoptosis chemotherapy cancer nanoerythrosome nanoerythrocyte nanovesicles biomimetic cancer therapy diagnostics imaging agents cell cycle cyclin-dependent kinase p16 p21 p27 breast cancer prognosis drug delivery HL60 leukemia prodrug resistance retinoic acid vitamin K drug repurposing COVID-19 pandemic vaccination multi-drug resistance enhanced permeation and retention effect nanotherapeutics cancer theranostic clinical translation cell-penetrating peptides protein transduction domains tumor imaging targeted therapies dog comparative oncology molecular targets spheroids tumoroids hydrogel collagen agarose mammary spheroids tissue engineering cisplatin melanoma melanin nanoparticles cytotoxicity laser medical applications hyperthermia antimitotics mitotic slippage spindle assembly checkpoint clinical trials TRAIL cancer stem cells TRAIL resistance angiogenesis on-demand drug delivery systems electrospun nanofibers poly (N-isopropylacrylamide) gold nanorods paclitaxel β-Cyclodextrin SPIONs metallodrugs RAPTA derivatives phosphino-amine ligands CTCs NSCLCs metastasis suppression curcumin flavonoids TNBC immunotherapy immune checkpoint nanocarrier combinational immunotherapy lung cancer miRNA oncomiRs photodynamic therapy PDT porphyrin iron oxide nanoparticles mesoporous silica nanoparticles antibody functionalization targeted drug delivery systems molecular-targeted therapies multifunctional enzymes HCC CHRNA5 metastasis stemness property sorafenib sensitivity neoantigens vaccine Patched chemotherapy resistance metastases persistent cells adrenocortical carcinoma BUB3 mitosis senescence anticancer target boron neutron capture therapy 4-borono-l-phenylalanine drug discovery solubility mebendazole polymer HPMA controlled drug release PLK1 BI2536 Navitoclax slippage PD-1 gemcitabine new anti-cancer drugs precision medicine undruggable targets non-coding RNAs oligonucleotide therapeutics n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230405_9783036570334_212 |